TY - JOUR AU - Arnaout, A. AU - Lee, J. AU - Gelmon, K. AU - Poirier, B. AU - Lu, F. I. AU - Akra, M. PY - 2018 DA - 2018// TI - Neoadjuvant therapy for breast cancer: updates and proceedings from the seventh annual meeting of the Canadian Consortium for Locally Advanced Breast Cancer JO - Curr Oncol VL - 25 UR - https://doi.org/10.3747/co.25.4153 DO - 10.3747/co.25.4153 ID - Arnaout2018 ER - TY - JOUR AU - Maur, M. AU - Guarneri, V. AU - Frassoldati, A. AU - Conte, P. F. PY - 2006 DA - 2006// TI - Primary systemic therapy in operable breast cancer: clinical data and biological fall-out JO - Ann Oncol VL - 17 UR - https://doi.org/10.1093/annonc/mdj973 DO - 10.1093/annonc/mdj973 ID - Maur2006 ER - TY - JOUR AU - Untch, M. AU - Konecny, G. E. AU - Paepke, S. AU - Minckwitz, G. PY - 2014 DA - 2014// TI - Current and future role of neoadjuvant therapy for breast cancer JO - Breast. VL - 23 UR - https://doi.org/10.1016/j.breast.2014.06.004 DO - 10.1016/j.breast.2014.06.004 ID - Untch2014 ER - TY - JOUR AU - Yeh, E. AU - Slanetz, P. AU - Kopans, D. B. AU - Rafferty, E. AU - Georgian-Smith, D. AU - Moy, L. PY - 2005 DA - 2005// TI - Prospective comparison of mammography, sonography, and MRI in patients undergoing neoadjuvant chemotherapy for palpable breast cancer JO - Am J Roentgenol VL - 184 UR - https://doi.org/10.2214/ajr.184.3.01840868 DO - 10.2214/ajr.184.3.01840868 ID - Yeh2005 ER - TY - JOUR AU - Croshaw, R. AU - Shapiro-Wright, H. AU - Svensson, E. AU - Erb, K. AU - Julian, T. PY - 2011 DA - 2011// TI - Accuracy of clinical examination, digital mammogram, ultrasound, and MRI in determining postneoadjuvant pathologic tumor response in operable breast cancer patients JO - Ann Surg Oncol VL - 18 UR - https://doi.org/10.1245/s10434-011-1919-5 DO - 10.1245/s10434-011-1919-5 ID - Croshaw2011 ER - TY - STD TI - Marinovich ML, Macaskill P, Irwig L, Sardanelli F, Mamounas E, von Minckwitz G, et al. Agreement between MRI and pathologic breast tumor size after neoadjuvant chemotherapy, and comparison with alternative tests: individual patient data meta-analysis. BMC Cancer. 2015;15(1). https://doi.org/10.1186/s12885-015-1664-4. ID - ref6 ER - TY - JOUR AU - Marinovich, M. L. AU - Houssami, N. AU - MacAskill, P. AU - Sardanelli, F. AU - Irwig, L. AU - Mamounas, E. P. PY - 2013 DA - 2013// TI - Meta-analysis of magnetic resonance imaging in detecting residual breast cancer after neoadjuvant therapy JO - J Natl Cancer Inst VL - 105 UR - https://doi.org/10.1093/jnci/djs528 DO - 10.1093/jnci/djs528 ID - Marinovich2013 ER - TY - JOUR AU - Lobbes, M. B. I. AU - Prevos, R. AU - Smidt, M. AU - Tjan-Heijnen, V. C. G. AU - Goethem, M. AU - Schipper, R. PY - 2013 DA - 2013// TI - The role of magnetic resonance imaging in assessing residual disease and pathologic complete response in breast cancer patients receiving neoadjuvant chemotherapy: a systematic review JO - Insights Imaging VL - 4 UR - https://doi.org/10.1007/s13244-013-0219-y DO - 10.1007/s13244-013-0219-y ID - Lobbes2013 ER - TY - JOUR AU - Haraldsdóttir, K. H. AU - Jónsson AU - Halldórsdóttir, A. B. AU - Tranberg, K. G. AU - Ásgeirsson, K. S. PY - 2017 DA - 2017// TI - Tumor size of invasive breast cancer on magnetic resonance imaging and conventional imaging (mammogram/ultrasound): comparison with pathological size and clinical implications JO - Scand J Surg VL - 106 UR - https://doi.org/10.1177/1457496916631855 DO - 10.1177/1457496916631855 ID - Haraldsdóttir2017 ER - TY - JOUR AU - Nitz, U. A. AU - Gluz, O. AU - Christgen, M. AU - Grischke, E. M. AU - Augustin, D. AU - Kuemmel, S. PY - 2017 DA - 2017// TI - De-escalation strategies in HER2-positive early breast cancer (EBC): final analysis of the WSG-ADAPT HER2+/HR- phase II trial: efficacy, safety, and predictive markers for 12 weeks of neoadjuvant dual blockade with trastuzumab and pertuzumab ± weekly pacl JO - Ann Oncol VL - 28 UR - https://doi.org/10.1093/annonc/mdx494 DO - 10.1093/annonc/mdx494 ID - Nitz2017 ER - TY - JOUR AU - Gluz, O. AU - Nitz, U. AU - Liedtke, C. AU - Christgen, M. AU - Grischke, E. M. AU - Forstbauer, H. PY - 2018 DA - 2018// TI - Comparison of neoadjuvant Nab-paclitaxel1carboplatin vs nab-paclitaxel1gemcitabine in triple-negative breast cancer: randomized WSG-ADAPT-TN trial results JO - J Natl Cancer Inst VL - 110 UR - https://doi.org/10.1093/jnci/djx258 DO - 10.1093/jnci/djx258 ID - Gluz2018 ER - TY - STD TI - Hofmann D, Nitz U, Gluz O, Kates RE, Schinkoethe T, Staib P, et al. WSG ADAPT - adjuvant dynamic marker-adjusted personalized therapy trial optimizing risk assessment and therapy response prediction in early breast cancer: Study protocol for a prospective, multi-center, controlled, non-blinded, randomized, investigator in. Trials. 2013;14(1). https://doi.org/10.1186/1745-6215-14-261. ID - ref12 ER - TY - JOUR AU - Harbeck, N. AU - Gluz, O. AU - Christgen, M. AU - Kates, R. E. AU - Braun, M. AU - Küemmel, S. PY - 2017 DA - 2017// TI - De-escalation strategies in human epidermal growth factor receptor 2 (HER2)–positive early breast cancer (BC): final analysis of the West German Study Group adjuvant dynamic marker-adjusted personalized therapy trial optimizing risk assessment and therapy JO - J Clin Oncol VL - 35 UR - https://doi.org/10.1200/JCO.2016.71.9815 DO - 10.1200/JCO.2016.71.9815 ID - Harbeck2017 ER - TY - STD TI - Breast Imaging Reporting & Data System | American College of Radiology. ACR BI-RADS Atlas® 5th Edition. https://www.acr.org/Clinical-Resources/Reporting-and-Data-Systems/Bi-Rads#MRI [Internet]. UR - https://www.acr.org/Clinical-Resources/Reporting-and-Data-Systems/Bi-Rads#MRI ID - ref14 ER - TY - JOUR AU - Baumgartner, A. AU - Tausch, C. AU - Hosch, S. AU - Papassotiropoulos, B. AU - Varga, Z. AU - Rageth, C. PY - 2018 DA - 2018// TI - Ultrasound-based prediction of pathologic response to neoadjuvant chemotherapy in breast cancer patients JO - Breast. VL - 39 UR - https://doi.org/10.1016/j.breast.2018.02.028 DO - 10.1016/j.breast.2018.02.028 ID - Baumgartner2018 ER - TY - JOUR AU - Gampenrieder, S. P. AU - Peer, A. AU - Weismann, C. AU - Meissnitzer, M. AU - Rinnerthaler, G. AU - Webhofer, J. PY - 2019 DA - 2019// TI - Radiologic complete response (rCR) in contrast-enhanced magnetic resonance imaging (CE-MRI) after neoadjuvant chemotherapy for early breast cancer predicts recurrence-free survival but not pathologic complete response (pCR) JO - Breast Cancer Res VL - 21 UR - https://doi.org/10.1186/s13058-018-1091-y DO - 10.1186/s13058-018-1091-y ID - Gampenrieder2019 ER - TY - JOUR AU - Scheel, J. R. AU - Kim, E. AU - Partridge, S. C. AU - Lehman, C. D. AU - Rosen, M. A. AU - Bernreuter, W. K. PY - 2018 DA - 2018// TI - MRI, clinical examination, and mammography for preoperative assessment of residual disease and pathologic complete response after neoadjuvant chemotherapy for breast cancer: ACRIN 6657 trial JO - Am J Roentgenol VL - 210 UR - https://doi.org/10.2214/AJR.17.18323 DO - 10.2214/AJR.17.18323 ID - Scheel2018 ER - TY - JOUR AU - Vriens, B. E. P. J. AU - Vries, B. AU - Lobbes, M. B. I. AU - Gastel, S. M. AU - Berkmortel, F. W. P. J. AU - Smilde, T. J. PY - 2016 DA - 2016// TI - Ultrasound is at least as good as magnetic resonance imaging in predicting tumour size post-neoadjuvant chemotherapy in breast cancer JO - Eur J Cancer VL - 52 UR - https://doi.org/10.1016/j.ejca.2015.10.010 DO - 10.1016/j.ejca.2015.10.010 ID - Vriens2016 ER - TY - JOUR AU - Segara, D. AU - Krop, I. E. AU - Garber, J. E. AU - Winer, E. AU - Harris, L. AU - Bellon, J. R. PY - 2007 DA - 2007// TI - Does MRI predict pathologic tumor response in women with breast cancer undergoing preoperative chemotherapy? JO - J Surg Oncol VL - 96 UR - https://doi.org/10.1002/jso.20856 DO - 10.1002/jso.20856 ID - Segara2007 ER - TY - JOUR AU - Guarneri, V. AU - Pecchi, A. AU - Piacentini, F. AU - Barbieri, E. AU - Dieci, M. V. AU - Ficarra, G. PY - 2011 DA - 2011// TI - Magnetic resonance imaging and ultrasonography in predicting infiltrating residual disease after preoperative chemotherapy in stage II-III breast cancer JO - Ann Surg Oncol VL - 18 UR - https://doi.org/10.1245/s10434-011-1590-x DO - 10.1245/s10434-011-1590-x ID - Guarneri2011 ER - TY - JOUR AU - Moon, H. G. AU - Han, W. AU - Lee, J. W. AU - Ko, E. AU - Kim, E. K. AU - Yu, J. H. PY - 2009 DA - 2009// TI - Age and HER2 expression status affect MRI accuracy in predicting residual tumor extent after neo-adjuvant systemic treatment JO - Ann Oncol VL - 20 UR - https://doi.org/10.1093/annonc/mdn683 DO - 10.1093/annonc/mdn683 ID - Moon2009 ER - TY - JOUR AU - Nakahara, H. AU - Yasuda, Y. AU - Machida, E. AU - Maeda, Y. AU - Furusawa, H. AU - Komaki, K. PY - 2011 DA - 2011// TI - MR and US imaging for breast cancer patients who underwent conservation surgery after neoadjuvant chemotherapy: comparison of triple negative breast cancer and other intrinsic subtypes JO - Breast Cancer VL - 18 UR - https://doi.org/10.1007/s12282-010-0235-4 DO - 10.1007/s12282-010-0235-4 ID - Nakahara2011 ER - TY - JOUR AU - Marinovich, M. L. AU - Macaskill, P. AU - Irwig, L. AU - Sardanelli, F. AU - Minckwitz, G. AU - Mamounas, E. PY - 2013 DA - 2013// TI - Meta-analysis of agreement between MRI and pathologic breast tumour size after neoadjuvant chemotherapy JO - Br J Cancer VL - 109 UR - https://doi.org/10.1038/bjc.2013.473 DO - 10.1038/bjc.2013.473 ID - Marinovich2013 ER - TY - JOUR AU - Chen, J. H. AU - Bahri, S. AU - Mehta, R. S. AU - Carpenter, P. M. AU - McLaren, C. E. AU - Chen, W. P. PY - 2014 DA - 2014// TI - Impact of factors affecting the residual tumor size diagnosed by MRI following neoadjuvant chemotherapy in comparison to pathology JO - J Surg Oncol VL - 109 UR - https://doi.org/10.1002/jso.23470 DO - 10.1002/jso.23470 ID - Chen2014 ER - TY - JOUR AU - Mukhtar, R. A. AU - Yau, C. AU - Rosen, M. AU - Tandon, V. J. AU - Hylton, N. AU - Esserman, L. J. PY - 2013 DA - 2013// TI - Clinically meaningful tumor reduction rates vary by prechemotherapy MRI phenotype and tumor subtype in the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657) JO - Ann Surg Oncol VL - 20 UR - https://doi.org/10.1245/s10434-013-3038-y DO - 10.1245/s10434-013-3038-y ID - Mukhtar2013 ER - TY - JOUR AU - Denis, F. AU - Desbiez-Bourcier, A. V. AU - Chapiron, C. AU - Arbion, F. AU - Body, G. AU - Brunereau, L. PY - 2004 DA - 2004// TI - Contrast enhanced magnetic resonance imaging underestimates residual disease following neoadjuvant docetaxel based chemotherapy for breast cancer JO - Eur J Surg Oncol VL - 30 UR - https://doi.org/10.1016/j.ejso.2004.07.024 DO - 10.1016/j.ejso.2004.07.024 ID - Denis2004 ER -